AmerisourceBergen Q1 Earnings Surpass Expectations, Boosts Annual Guidance

  • AmerisourceBergen Corp's ABC Q1 FY23 adjusted EPS reached $2.71, up 5% Y/Y, beating the consensus of $2.63.
  • Revenue of $62.85 billion increased by 5.4% Y/Y, beating the analyst consensus of $62.67 billion, reflecting a 6.1% increase in U.S. Healthcare Solutions revenue and a 0.6% decrease in revenue within International Healthcare Solutions due to the negative impact of foreign currency translation.
  • On a constant currency basis, revenue was up 7.5%, reflecting 17.7% constant currency growth in International Healthcare Solutions revenue.
  • Also Read: US Authority Plans Massive Expansion Of Medication Access To Combat Opioid Overdose Crisis.
  • Adjusted gross profit was $2.1 billion, up 5.4% Y/Y, with the margin flat Y/Y at 3.38%.
  • Adjusted operating income decreased by 2.1% to $734 million, and the margin decreased by nine basis points to 1.17%.
  • FY23 Guidance: AmerisourceBergen raised the FY23 adjusted EPS guidance to $11.50 to $11.75 from $11.30-$11.60, compared to the consensus of $11.51.
  • Excluding contributions related to COVID-19, adjusted operating income growth is expected to be around 4%-6%, up from the previous range of 3%-5%.
  • Last week, the company announced its intention to change its name to Cencora and expects to begin operating under the new moniker in 2H of CY2023.
  • Price Action: ABC shares are down 1.66% at $166.15 on the last check Wednesday.
  • Photo Via Company
Market News and Data brought to you by Benzinga APIs
Posted In: EarningsLarge CapNewsGuidanceHealth CareGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!